37 events hosted · 47 upcoming
From Models to Systems: AI Infra in the Agentic Era
📍 Magnolia Ballroom I, 3F, Jing An Shangri-La, Shanghai
Panel: The Next Journey of HealthTech — Innovation, Transformation and Inclusive Value
📍 Jing An Grand Ballroom III, 5F, Jing An Shangri-La, Shanghai
Algorithmic E-commerce: AI Reshaping Brand Dominance
Multimodal BioCV Models and BCI: Commercialising Full-Stack BCI
Latest Thoughts on Hong Kong's Life Science Capital Market
📍 Jing An Grand Ballroom I, 5F, Jing An Shangri-La, Shanghai
Cancer Screening and Insurance Reimbursement
📍 Jing An Grand Ballroom II, 5F, Jing An Shangri-La, Shanghai
A New Chapter for Hong Kong's Capital Markets
📍 Magnolia Ballroom II, 3F, Jing An Shangri-La, Shanghai
Redefining Fertility: The Future of Precision Reproductive Medicine
White Paper Release: Global Brain-Computer Interface Industry (2026)
Macro Hedging Trading Amid the AI Technological Revolution
Blue Book Release 2: Global Gene Therapy Industry (2026)
Trends in Ophthalmic Medical Devices
White Paper Release 2: China AI Advancement and Leap
tLNP Platform for In Vivo CAR-T: Tumour and Autoimmune Dual Tracks
Building an AI-Native Product from 0 to 1
Biomanufacturing: A Decade of Leapfrogging from Synthetic Biology to Industrialisation
My Life Journey in Membrane Technology
The Commercial Path of Medical Imaging AGI
Panel: Breakthroughs of Chinese AI Amid the US-China AI Rivalry
Revolution in Large-Scale MSC Production: 3D FloTrix
Industry Status and Prospects of Humanoid Robots
AI + Biomanufacturing: Cell Factories and Precision Nutrition
Blue Book Release: Global Digital Intelligent Medical Imaging (2026)
Platform-Compound Strategy Driven by Biocatalytic Technology
Analysis of iNKT Market Status and Future Trends
PFA Acceleration: Cardiac Electrophysiology Enters a New Cycle
Panel: Pathways to Unlocking the Commercial Value of AI
White Paper Release: Global Synthetic Biology Industry Development 2026
Discovery of Novel Peptide-Drug Conjugates (PDC)
Cardiovascular Intervention After Volume-Based Procurement
2026 H2 Hong Kong Equity Strategy: The New IPO Ecosystem
Interpretation of ECM Research Progress and Application Prospects
AI in Peptide Drug Discovery
How Fluorescence Navigation Redefines Precision Tumour Surgery
Operation in the AI Era: From Business Evolution to Enduring Prosperity
Programmable RNA Design Based on Virtual Life AI
Forging a Long-Termist Philosophy in Aesthetic Medicine Materials
Empower the Future with Wisdom; Cultivate Self and Inspire Others
Innovation-Driven Full Lifecycle Solutions
A Revolution in Tumour Treatment: BNCT
From Nature's Loom to Beauty's Boom: Silk Fibroin's Regenerative Potential
Dalipal's Exploration and Practice of Global Expansion
Panel: AI Reshaping R&D — China Biopharma's AI Moment
Panel: Collaboration Models Driving Medical Device Innovation
Strategic Choices and Valuation Logic for AI Companies Listing in Hong Kong
Panel: The Commercialisation Turning Point for Regenerative Aesthetic Medicine
Panel: Global Deployment & AI Empowerment
Panel: China's Medical Devices — From Clinical Innovation to Global Expansion
Decision Intelligence: The Third Pole of AI Reshaping the Industrial Economy
Panel: Navigating Capital Markets for New Economy Enterprises
BCI and Multimodal Fusion: A New Paradigm for Precise Sleep Regulation
Panel: Building a Global Ecosystem for China's Innovative Drugs
A New Era of Human-Machine Symbiosis: Next-Generation Robots
Compliant and Effective Market Value Management for HK-Listed Companies
Minimally Invasive Interventional Therapy: A New Era of Chronic Disease Management
Blue Book Release: China Biopharma International Development (2026)
Brain as a Platform: Is the Endgame of BCI Healthcare or Evolution?
White Paper Release: Global Brain-Computer Interface Industry
Blue Book Release: Global AI Healthcare Industry Development (2026)
Unleashing the Value of Data: Tencent Cloud Powers Embodied Intelligence
Mitigating Legal Risks in Outbound M&A for Chinese Companies
Millimetre-wave Radar: Where Sensing Meets Computing
Medical-grade AI and a Closed-Loop Model for Pharmaceutical Digital Marketing
Clinical Leaps in Non-invasive Brain-Computer Interfaces
Hengrui Pharma's Innovative R&D and Internationalisation
From Connection to Collaboration: Breaking the Stalemate of Industrial Agents
The Rise of China Robotics
A New Ecosystem for Medical Services: From End-Point Perception to Smart Decision-Making
China's Medical Device Industry: Trends and Investment Landscape
Innovation Origins and Global Connectivity: China and Shanghai Biopharma
Core Infrastructure for AI: The Leap and Reconstruction of AI Data Services
